[Recommendations for immunosuppressive therapy in systemic lupus erythematosus].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000974:Antibodies, Antinuclear / Q000032:analysis; D001171:Arthritis, Juvenile / Q000175:diagnosis / Q000188:drug therapy*; D001379:Azathioprine / Q000627:therapeutic use; D001853:Bone Marrow; D002648:Child; D003168:Complement Fixation Tests; D003520:Cyclophosphamide / Q000627:therapeutic use; D005455:Fluorescent Antibody Technique; D005921:Glomerulonephritis / Q000175:diagnosis; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000188:drug therapy*; D015122:Mercaptopurine / Q000627:therapeutic use; D009504:Neutrophils; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012698:Serologic Tests; D014652:Vascular Diseases / Q000175:diagnosis
D000974:Antibodies, Antinuclear; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D000324:Adrenocorticotropic Hormone; D011239:Prednisolone; D015122:Mercaptopurine; D001379:Azathioprine; D011241:Prednisone
Empfehlungen zur immunsuppressiven Therapie beim Lupus erythematodes visceralis.